Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Galimberti

Showing results (11-20 of 313) with videos related to

Pageof 32
Sort By:
Leukemia Research|November 23, 2006
Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1alpha-25-dihydroxyvitamin D3, as differentiating agentEnrico Orciuolo, Nadia Cecconi, Sara Galimberti, et al.
Frontiers in Oncology|October 16, 2019
BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid LeukemiaFederica Loscocco, Giuseppe Visani, Sara Galimberti, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
How First-Line Therapy is Changing in Transplant-Eligible Multiple Myeloma PatientsYasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, et al.
Annals of Hematology|December 20, 2007
False positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphomaDaniele Focosi, Francesco Caracciolo, Sara Galimberti, et al.
Leukemia Research|June 15, 2007
Association of PIM gene translocation and TEL/AML1 rearrangementGabriele Buda, Enrico Orciuolo, Sara Galimberti, et al.
Acta Haematologica|September 5, 2009
Bortezomib and liposomal doxorubicin are highly effective in obtaining the best possible response before autologous transplant for multiple myelomaGabriele Buda, Enrico Orciuolo, Sara Galimberti, et al.
Annals of Hematology|September 12, 2007
Long-term propylthiouracil use and acute myeloid leukemia: a case report and review of the literatureDaniele Focosi, Francesco Caracciolo, Sara Galimberti, et al.
Anticancer Research|October 7, 2017
<i>GTF2I</i> Mutations Are Common in Thymic Epithelial Tumors But Not in Hematological MalignanciesGiulia Tarrini, Elena Ciabatti, Simone Pacini, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Monoclonal Antibodies in Relapsed-Refractory Multiple MyelomaIlaria Sorgiovanni, Maria Livia Del Giudice, Sara Galimberti, et al.
Annals of Hematology|December 25, 2010
Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patientsGabriele Buda, Enrico Orciuolo, Sara Galimberti, et al.
Pageof 32

Showing results (11-20 of 313) with videos related to

Sort By:
Pageof 32
Leukemia Research|November 23, 2006
Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1alpha-25-dihydroxyvitamin D3, as differentiating agentEnrico Orciuolo, Nadia Cecconi, Sara Galimberti, et al.
Frontiers in Oncology|October 16, 2019
BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid LeukemiaFederica Loscocco, Giuseppe Visani, Sara Galimberti, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
How First-Line Therapy is Changing in Transplant-Eligible Multiple Myeloma PatientsYasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, et al.
Annals of Hematology|December 20, 2007
False positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphomaDaniele Focosi, Francesco Caracciolo, Sara Galimberti, et al.
Leukemia Research|June 15, 2007
Association of PIM gene translocation and TEL/AML1 rearrangementGabriele Buda, Enrico Orciuolo, Sara Galimberti, et al.
Acta Haematologica|September 5, 2009
Bortezomib and liposomal doxorubicin are highly effective in obtaining the best possible response before autologous transplant for multiple myelomaGabriele Buda, Enrico Orciuolo, Sara Galimberti, et al.
Annals of Hematology|September 12, 2007
Long-term propylthiouracil use and acute myeloid leukemia: a case report and review of the literatureDaniele Focosi, Francesco Caracciolo, Sara Galimberti, et al.
Anticancer Research|October 7, 2017
<i>GTF2I</i> Mutations Are Common in Thymic Epithelial Tumors But Not in Hematological MalignanciesGiulia Tarrini, Elena Ciabatti, Simone Pacini, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Monoclonal Antibodies in Relapsed-Refractory Multiple MyelomaIlaria Sorgiovanni, Maria Livia Del Giudice, Sara Galimberti, et al.
Annals of Hematology|December 25, 2010
Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patientsGabriele Buda, Enrico Orciuolo, Sara Galimberti, et al.
Pageof 32